# Informed Consent in Research: What It Is and Why It Matters ## Quick Answer - Informed consent is the ethical and regulatory process of ensuring a participant voluntarily agrees to research after understanding the study's purpose, procedures, risks, and benefits. - The practical next step for researchers is to draft a consent document that covers all required elements and submit it to the appropriate institutional review board before enrolling any participant. - A key limitation is that consent is an ongoing process, not a one-time form, and researchers must remain alert to participant comprehension and voluntariness throughout the study. ## The Ethical Foundation of Informed Consent Informed consent rests on the principle of respect for persons, which holds that individuals are autonomous agents entitled to make their own decisions about participating in research. This principle also requires that people with diminished autonomy, such as children, prisoners, or those with cognitive impairments, receive additional protections. The ethical weight of informed consent comes from the recognition that research participants are not means to an end but partners in a shared enterprise of knowledge creation. The historical roots of informed consent trace to responses to research abuses. The Nuremberg Code, developed after World War II, established that voluntary consent is absolutely essential for human subjects research. Later declarations and regulations refined this foundation, adding requirements for disclosure, comprehension, and voluntariness. In the United States, the Common Rule codified these principles into federal regulations that govern most federally funded human subjects research. The ethical rationale extends beyond legal compliance. Informed consent protects participants from harm by ensuring they understand what will happen to them. It promotes trust in the research enterprise, which depends on public willingness to participate. It also distributes responsibility, making clear that researchers must justify their actions to participants instead of assuming authority over them. Researchers should understand that informed consent is not a bureaucratic hurdle but a moral commitment. The process demonstrates respect for the person's right to self-determination. When researchers approach consent as a meaningful conversation instead of a formality, they strengthen the ethical quality of their work and the validity of their data. ## Regulatory Framework and Institutional Oversight In the United States, the Department of Health and Human Services and the Food and Drug Administration issue regulations that govern human subjects research. The Common Rule, codified at 45 CFR Part 46, applies to research conducted or supported by federal agencies. The FDA regulations at 21 CFR Parts 50 and 56 apply to research involving drugs, biologics, and medical devices. Researchers must determine which regulations apply to their specific study based on funding sources and the nature of the intervention. Institutional review boards, commonly called IRBs, serve as the primary oversight mechanism for human subjects research. An IRB reviews research protocols to ensure they meet ethical standards and regulatory requirements before participants are enrolled. The board evaluates the risk-benefit ratio, the adequacy of the consent process, and the protections for vulnerable populations. IRBs have the authority to approve, require modifications to, or disapprove research activities. The National Institutes of Health provides guidance on the responsible conduct of research, which includes informed consent as a core component. NIH-funded researchers must complete training in responsible conduct of research and must ensure that their institutions have policies in place to address ethical issues. The NIH Grants and Funding portal offers information about the expectations for grant applicants and awardees regarding human subjects protections. Researchers should understand that IRB review is not a single event but an ongoing process. Any significant changes to the approved protocol, including changes to the consent process or documents, require IRB review and approval before implementation. Annual continuing review ensures that the research remains consistent with the approved protocol and that any new information about risks or benefits is considered. ## Core Elements of Informed Consent The federal regulations specify eight basic elements that must be included in informed consent documents. These elements ensure that participants receive the information they need to make an informed decision about participation. The first element is a statement that the study involves research, an explanation of the purposes of the research, the expected duration of participation, and a description of the procedures to be followed. This element also requires identification of any procedures that are experimental. Participants must understand that they are being asked to contribute to knowledge, not simply to receive treatment or services. The second element is a description of any reasonably foreseeable risks or discomforts. Researchers must disclose risks honestly, even when they are unlikely or minor. The description should be understandable to a layperson and should not minimize potential harms. The third element is a description of any benefits to the participant or to others that may reasonably be expected from the research. If there are no direct benefits, the consent document should state this clearly. Participants should not be led to expect benefits that the research cannot deliver. The fourth element is a disclosure of appropriate alternative procedures or courses of treatment that might be advantageous to the participant. This element is particularly important in clinical research where participants may have treatment options outside the study. The fifth element is a statement describing the extent to which confidentiality of records identifying the participant will be maintained. Researchers must explain who will have access to the data and what measures will be taken to protect privacy. The sixth element is an explanation of whether any compensation or medical treatments are available if injury occurs. This element applies to research involving more than minimal risk and must describe what the participant can expect in the event of harm. The seventh element is an explanation of whom to contact for answers to questions about the research, the rights of research participants, and research-related injuries. Contact information must include the researcher, the IRB, and any other relevant parties. The eighth element is a statement that participation is voluntary, that refusal to participate will involve no penalty or loss of benefits, and that the participant may discontinue participation at any time without penalty or loss of benefits. ## The Consent Process as Ongoing Communication Informed consent is not a single event that ends when the participant signs the form. It is an ongoing process of communication between the researcher and the participant that begins before enrollment and continues throughout the study. Researchers should view each interaction with a participant as an opportunity to reinforce understanding and address questions. The initial consent conversation should occur in a setting that allows the participant to ask questions without pressure. Researchers should use plain language and avoid jargon. They should check for understanding by asking the participant to explain the study in their own words. This teach-back method helps identify misunderstandings that the consent document alone might not reveal. During the study, researchers should provide new information that may affect the participant's willingness to continue. If interim findings suggest that risks are greater than initially described, or that the study is unlikely to achieve its goals, participants must be informed. The consent document should be updated and re-signed when substantive changes occur. Researchers should also recognize that participants may forget details of the study over time. Periodic reminders about the study's purpose, procedures, and the voluntary nature of participation can help maintain genuine consent. This is especially important in long-term studies where participants may lose sight of why they enrolled. The ongoing nature of consent means that researchers must be attentive to verbal and nonverbal cues that suggest a participant is uncomfortable or wishes to withdraw. A participant who misses appointments, expresses reluctance, or asks about stopping should be given clear information about how to withdraw and what will happen to their data. ## Vulnerable Populations and Special Protections Certain groups of people require additional protections in the consent process because their ability to make voluntary, informed decisions may be compromised. The regulations identify children, prisoners, pregnant women, human fetuses, and neonates as vulnerable populations requiring special safeguards. Researchers must understand the specific requirements for each group. Children cannot provide legal consent, so researchers must obtain permission from parents or guardians and assent from the children themselves. Assent means that the child agrees to participate in a manner appropriate to their age and maturity. The regulations require that researchers involve children in the decision to the extent they are capable. A child who objects to participation should not be enrolled, even with parental permission. Prisoners are considered vulnerable because their confinement may compromise their ability to make voluntary decisions. Research involving prisoners must be reviewed by an IRB that includes a prisoner representative. The regulations restrict the types of research that may be conducted with prisoners and require that the research hold the potential to benefit prisoners as a class. Adults with diminished capacity, such as those with dementia, intellectual disabilities, or severe mental illness, may require surrogate consent from a legally authorized representative. Researchers must assess capacity to consent and should use enhanced consent procedures, such as repeated discussions and simplified materials, when appropriate. Researchers working with vulnerable populations should document their plans for protecting these participants in the research protocol. The IRB will evaluate whether the proposed protections are adequate. Researchers should also be prepared to demonstrate that the research could not be conducted with a less vulnerable population and that the risks are minimized. ## Comprehension and Voluntariness Two conditions must be met for consent to be valid: the participant must comprehend the information presented, and the decision to participate must be voluntary. Both conditions present practical challenges that researchers must address. Comprehension requires more than the ability to read the consent document. Participants must understand the study's purpose, what will happen to them, the risks involved, and their rights. Reading level is a common barrier. Consent documents written at advanced reading levels may be incomprehensible to participants with limited literacy. Researchers should assess the reading level of consent materials and revise them to match the target population. Cultural and linguistic factors also affect comprehension. Participants who do not speak English fluently must receive consent materials in a language they understand. The consent process should be conducted in the participant's preferred language, using qualified interpreters when necessary. Researchers should not rely on family members to interpret because this may compromise confidentiality and accuracy. Voluntariness means that the participant's decision is free from undue influence or coercion. Coercion involves explicit or implicit threats, such as suggesting that refusing to participate will result in loss of medical care or other benefits. Undue influence involves excessive or inappropriate inducements that may cloud judgment. Researchers must be careful not to offer payments so large that they become the primary reason for participation. The therapeutic misconception is a related concern. Participants in clinical research may mistakenly believe that the research procedures are designed for their personal benefit instead of for the generation of knowledge. Researchers must clearly distinguish between research procedures and standard care and must ensure that participants understand that the primary purpose of the study is to answer a scientific question. ## Documentation and Record Keeping The consent document serves as the record of the consent process. Federal regulations require that consent be documented in writing, signed by the participant or the legally authorized representative, and dated. A copy of the signed consent form must be given to the participant. The researcher must retain the original in the research records. The consent document should be version-controlled. When the protocol changes, the consent document must be updated and approved by the IRB. Researchers should maintain a log of consent document versions and the dates they were in use. This practice helps ensure that all participants receive the most current information. Researchers should also document the consent process itself. Notes about who conducted the consent conversation, what questions the participant asked, and how comprehension was assessed can be valuable if questions arise later. This documentation is especially important when consent is obtained in unusual circumstances, such as in emergency research where consent may be waived or deferred. The National Institutes of Health Data Management and Sharing Policy requires researchers to plan for the management and sharing of scientific data generated by NIH-funded research. This policy has implications for consent because participants must be informed about how their data will be shared and used. Consent documents should describe data-sharing plans, including whether data will be de-identified and where it will be deposited. ## Common Failure Patterns in Informed Consent Researchers should be aware of common problems that undermine the quality of informed consent. Recognizing these patterns can help researchers avoid them and can help IRBs identify studies that need improvement. One common failure is the use of consent documents that are too long and too complex. Documents that exceed the reading level of the target population or that are filled with technical jargon fail to inform participants effectively. Researchers should prioritize clarity over completeness and should test consent materials with representative readers. Another failure is treating consent as a formality instead of a conversation. When researchers rush through the consent process or delegate it to staff who cannot answer questions, participants may sign without understanding. The consent conversation should be conducted by someone with adequate knowledge of the study and the skills to communicate effectively. A third failure is failing to update consent when new information emerges. Studies that continue for years may generate new risk information or may change procedures. Participants must be informed of these changes and given the opportunity to reconsider their participation. A fourth failure is inadequate attention to voluntariness. Researchers who recruit from their own patient populations or who offer substantial payments may inadvertently create pressure to participate. Researchers should be alert to situations where participants may feel obligated and should emphasize the voluntary nature of participation. A fifth failure is poor documentation. Missing signatures, undated forms, and unversioned documents create compliance problems and may compromise participant protections. Researchers should establish clear procedures for consent documentation and should audit their records regularly. ## Practical Steps for Implementing Informed Consent Researchers designing a study should follow a systematic approach to informed consent. The following steps provide a practical framework for developing and implementing a consent process that meets ethical and regulatory standards. First, identify the applicable regulations and institutional policies. Determine whether the research is subject to the Common Rule, FDA regulations, or both. Review the institution's policies on human subjects research and consent documentation. Second, draft the consent document using the required elements as a checklist. Write in plain language at an appropriate reading level. Have colleagues review the document for clarity and completeness. Test the document with people who represent the target population. Third, develop a consent process that goes beyond the document. Plan how the consent conversation will be conducted, who will conduct it, and how comprehension will be assessed. Prepare responses to common questions and plan for participants with limited literacy or English proficiency. Fourth, submit the consent document and process description to the IRB for review. Be prepared to revise the materials in response to IRB feedback. The IRB may require changes to the consent document, the process, or the protections for vulnerable populations. Fifth, implement the consent process with attention to quality. Conduct the consent conversation as planned, document the process, and provide the participant with a copy of the signed form. Monitor the process throughout the study and make adjustments as needed. Sixth, maintain records and respond to changes. Keep version-controlled consent documents and documentation of the consent process. When the protocol changes, update the consent document and obtain IRB approval before using it. Inform enrolled participants of changes that may affect their willingness to continue. ## At a Glance | Consent Element | What It Covers | Common Implementation Failure | | --- | --- | --- | | Study purpose and procedures | Explains the research nature, duration, and what will happen | Using technical jargon that participants cannot understand | | Risks and discomforts | Describes foreseeable harms honestly | Minimizing or omitting risks to encourage enrollment | | Benefits and alternatives | States expected benefits and alternative options | Overstating potential benefits or ignoring alternatives | | Confidentiality and data sharing | Explains who will access data and how it will be shared | Failing to describe data-sharing plans required by funders | | Voluntary participation | States that refusal or withdrawal carries no penalty | Creating pressure through recruitment from clinical populations | | Contact information | Provides contacts for questions and concerns | Listing contacts who are unavailable or unresponsive | ## Records and Measurements for Consent Quality Researchers can measure the quality of their consent process through several practical methods. These measurements help identify problems and demonstrate compliance with ethical standards. Comprehension assessments are one useful tool. Researchers can ask participants to answer a short quiz about the study after the consent conversation. Questions should cover the study's purpose, the procedures, the risks, and the voluntary nature of participation. A high rate of incorrect answers suggests that the consent process needs improvement. Readability analysis of consent documents provides another measurement. Several tools calculate reading grade level based on sentence length and word complexity. Researchers should aim for a reading level appropriate to the target population, which may be lower than the general population average. Documentation audits can identify compliance problems. Researchers should periodically review consent records to ensure that forms are signed, dated, and version-controlled. Missing documentation should be corrected immediately and patterns of errors should be investigated. Participant feedback can reveal problems that other measurements miss. Researchers can ask participants whether they felt informed, whether they had enough time to decide, and whether they felt pressured. This feedback should be collected in a way that allows honest responses, such as anonymous surveys. The National Institutes of Health Data Management and Sharing Policy requires researchers to include data-sharing plans in their grant applications and to describe these plans in consent documents. Researchers should track whether their consent documents accurately describe the data-sharing arrangements and whether participants were informed about how their data would be used. ## Welfare and Safety Context Informed consent is a component of the broader ethical obligation to protect research participants from harm. The consent process is not a substitute for sound study design, appropriate risk minimization, or ongoing safety monitoring. Researchers must attend to participant welfare throughout the study, also at enrollment. The Committee on Publication Ethics Core Practices emphasize that ethical conduct extends to the reporting of research. Researchers have obligations to report their findings honestly, to disclose conflicts of interest, and to ensure that authorship reflects actual contributions. These obligations connect to informed consent because participants must be able to trust that their contributions will be used responsibly. Researchers should also understand that consent does not absolve them of responsibility for participant welfare. A participant who consents to a study does not consent to negligence or to hidden risks. Researchers must continue to monitor for adverse events and must take appropriate action when problems arise. The EQUATOR Network provides reporting guidelines that help researchers report their studies transparently. Transparent reporting is an ethical obligation that complements informed consent. When researchers report their methods and findings clearly, they enable others to evaluate the research and to build on it responsibly. ## Professional Escalation Criteria Researchers should know when to seek additional guidance or escalate concerns about informed consent. The following situations warrant consultation with the IRB, institutional officials, or other appropriate authorities. If a participant appears to lack capacity to consent but no legally authorized representative is available, researchers should stop the enrollment process and consult the IRB. Proceeding without valid consent is a serious violation of ethical standards. If a participant reports that they did not understand the study or that they were pressured to participate, researchers should take the report seriously. The researcher should discuss the situation with the participant, offer the opportunity to withdraw, and report the concern to the IRB if appropriate. If new information emerges that suggests the risks of the study are greater than originally described, researchers must inform the IRB and the participants promptly. The IRB will determine whether the study should continue and whether the consent document needs revision. If a researcher discovers that consent was obtained improperly, such as through a missing signature or an outdated consent form, the researcher should report the finding to the IRB. The IRB will assess whether the participant was adequately informed and whether corrective action is needed. If a participant or family member raises concerns about the consent process, researchers should respond respectfully and document the concern. Unresolved concerns should be escalated to the IRB or to the institution's research integrity office. ## Frequently Asked Questions ### What is the difference between consent and assent in research? Consent is the formal permission given by an adult participant or a legally authorized representative. Assent is the agreement given by a child or a person who cannot provide legal consent. Assent must be obtained in a manner appropriate to the person's age and maturity, and it does not replace the need for parental permission or surrogate consent. ### Can a participant withdraw from a study after signing the consent form? Yes. Participation in research is always voluntary, and a participant may withdraw at any time without penalty or loss of benefits. The consent document must state this clearly. When a participant withdraws, researchers should discuss what will happen to data already collected and should follow the participant's wishes regarding continued data use. ### What happens if new risks are discovered during a study? Researchers must inform participants and the IRB promptly when new information suggests that risks are greater than originally described. The consent document must be updated to reflect the new information, and participants must be given the opportunity to reconsider their participation. The IRB will determine whether the study should continue. ### Are there situations where informed consent can be waived? Federal regulations allow IRBs to waive or alter consent requirements in limited circumstances. These include research that involves no more than minimal risk, where the waiver will not adversely affect the rights and welfare of participants, and where the research could not practicably be conducted without the waiver. Emergency research may also have special consent provisions. Researchers must obtain IRB approval for any waiver before proceeding. ### How should consent be handled for participants who do not speak English? Consent materials must be provided in a language the participant understands. The consent conversation should be conducted in the participant's preferred language, using a qualified interpreter when necessary. Researchers should not rely on family members to interpret because this may compromise confidentiality and accuracy. The IRB should review translated consent documents to ensure accuracy. ### What information must be included in a consent document? The consent document must include the eight basic elements required by federal regulations: a statement that the study involves research, a description of procedures, a description of risks, a description of benefits, a disclosure of alternatives, a statement about confidentiality, an explanation of compensation for injury, contact information, and a statement about voluntary participation. Additional elements may be required depending on the nature of the research. ### How long must consent records be retained? Institutional policies and applicable regulations determine record retention requirements. Researchers should follow their institution's policies for research records. The NIH Grants and Funding portal provides information about record-keeping expectations for NIH-funded research. Researchers should maintain consent records for the period required by their institution and by any applicable regulations. ### What is the researcher's responsibility if a participant seems confused during the consent process? The researcher should stop the consent conversation and assess the participant's understanding. The researcher should explain the information again in simpler terms and ask the participant to explain the study in their own words. If the participant still does not understand, the researcher should not enroll the participant and should consider whether the consent process needs to be revised for future participants. ## Using the Evidence | Source | Best use in this topic | Important limitation | |---|---|---| | [Research Methods Resources](https://www.ncbi.nlm.nih.gov/books) | official guidance | Check the linked page for current local requirements | | [EQUATOR Network](https://www.equator-network.org/) | official guidance | Check the linked page for current local requirements | | [Core Practices](https://publicationethics.org/core-practices) | official guidance | Check the linked page for current local requirements | ## Related Articles - [Informed Consent in Research: Principles and Common Pitfalls](/blog/guides/informed-consent-in-research-principles-and-common-pitfalls) - [Statistical Power: What It Is and Why It Matters in Research](/blog/guides/statistical-power-what-it-is-and-why-it-matters-in-research) - [The Role of the Research Ethics Committee: What Researchers Need to Know](/blog/guides/the-role-of-the-research-ethics-committee-what-researchers-need-to-know) - [Ethical Research Principles: A Guide to the Core Tenets](/blog/guides/ethical-research-principles-a-guide-to-the-core-tenets) - [What Are Research Ethics? Core Principles and Definitions](/blog/guides/what-are-research-ethics-core-principles-and-definitions) ## References and Further Reading - [Research Methods Resources](https://www.ncbi.nlm.nih.gov/books). National Library of Medicine. - [EQUATOR Network](https://www.equator-network.org/). EQUATOR Network. - [Core Practices](https://publicationethics.org/core-practices). Committee on Publication Ethics. - [NIH Grants and Funding](https://grants.nih.gov/). National Institutes of Health. - [ORCID for Researchers](https://info.orcid.org/researchers). ORCID. - [Data Management and Sharing Policy](https://sharing.nih.gov/data-management-and-sharing-policy). National Institutes of Health. - [NCBI Literature Resources](https://www.ncbi.nlm.nih.gov/). National Center for Biotechnology Information. - [PubMed](https://pubmed.ncbi.nlm.nih.gov/). National Library of Medicine. > This article is educational and does not replace institutional policy, professional advice, or applicable safety and regulatory requirements.